Lombard Odier Asset Management (Europe)’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-144,136
Closed -$9.2M 163
2025
Q1
$9.2M Sell
144,136
-19,535
-12% -$1.13M 0.74% 52
2024
Q4
$7.83M Buy
163,671
+38,671
+31% +$1.98M 0.5% 71
2024
Q3
$7.16M Sell
125,000
-75,000
-38% -$4.3M 0.3% 116
2024
Q2
$10.5M Buy
+200,000
New +$8.77M 0.5% 65
2023
Q2
Sell
-10,000
Closed -$382K 264
2023
Q1
$382K Sell
10,000
-9,500
-49% -$446K 0.02% 252
2022
Q4
$1.11M Sell
19,500
-500
-3% -$25.6K 0.05% 235
2022
Q3
$791K Hold
20,000
0.04% 231
2022
Q2
$880K Buy
+20,000
New +$865K 0.04% 216

Other funds holding HALO

Lombard Odier Asset Management (Europe)'s HALO Position: Q2 2025 in Review

Lombard Odier Asset Management (Europe) sold out of Halozyme (HALO) in Q2 2025, closing a stake of 144,136 shares — an estimated $9.2M sold.

Lombard Odier Asset Management (Europe) first reported a position in HALO in Q2 2022 and held it in 8 quarters. The position peaked at $10.5M in Q2 2024. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • Lombard Odier Asset Management (Europe) reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 144,136 Halozyme shares in Q2 2025, an estimated $9.2M.
  • Lombard Odier Asset Management (Europe) first reported a position in Halozyme in Q2 2022 and held it in 8 quarters.
  • Lombard Odier Asset Management (Europe)'s Halozyme position peaked at $10.5M in Q2 2024.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q2 2025, filed 14 Aug 2025.